Movement Alert｜RemeGen Rises 5.31% in Regular Trading, HK Biotech Sector Extends Rebound as Lock-Up Share Selling Restrictions Ease Overhang Concerns

Market Focus06-24

On June 24, RemeGen (09995.HK) rose 5.31% in regular trading, trading at HKD 70.05/share, with turnover of HKD 131 million.

On the news front, the HK biotech sector rallied for a second consecutive session, with AKESO up 4.33%, INNOVENT BIO up 3.92%, 3SBIO up 4.99%, BEIGENE up 3.6%, and SKB BIO up 7.44%, reflecting continued recovery in sector sentiment following the prior week's sell-off.

Additionally, the company previously announced that 193 million restricted shares from its IPO will become eligible for trading on July 1, representing 34.16% of total share capital. However, because the company has not met cash dividend distribution requirements under Shanghai Stock Exchange regulations, the unlocking shareholders are prohibited from reducing holdings through centralized bidding or block trading on A-shares. This regulatory restriction has substantially reduced actual selling pressure expectations, further alleviating market concerns over the potential overhang impact from the lock-up expiration.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1183890100?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 09:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183890100","market":"us","top_or_hot":-1,"title":"Movement Alert｜RemeGen Rises 5.31% in Regular Trading, HK Biotech Sector Extends Rebound as Lock-Up Share Selling Restrictions Ease Overhang Concerns","media":"Market Focus","content":"<p><p>On June 24, RemeGen (09995.HK) rose 5.31% in regular trading, trading at HKD 70.05/share, with turnover of HKD 131 million.</p><p>On the news front, the HK biotech sector rallied for a second consecutive session, with AKESO up 4.33%, INNOVENT BIO up 3.92%, 3SBIO up 4.99%, BEIGENE up 3.6%, and SKB BIO up 7.44%, reflecting continued recovery in sector sentiment following the prior week's sell-off.</p><p>Additionally, the company previously announced that 193 million restricted shares from its IPO will become eligible for trading on July 1, representing 34.16% of total share capital. However, because the company has not met cash dividend distribution requirements under Shanghai Stock Exchange regulations, the unlocking shareholders are prohibited from reducing holdings through centralized bidding or block trading on A-shares. This regulatory restriction has substantially reduced actual selling pressure expectations, further alleviating market concerns over the potential overhang impact from the lock-up expiration.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜RemeGen Rises 5.31% in Regular Trading, HK Biotech Sector Extends Rebound as Lock-Up Share Selling Restrictions Ease Overhang Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜RemeGen Rises 5.31% in Regular Trading, HK Biotech Sector Extends Rebound as Lock-Up Share Selling Restrictions Ease Overhang Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-24 09:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 24, RemeGen (09995.HK) rose 5.31% in regular trading, trading at HKD 70.05/share, with turnover of HKD 131 million.</p><p>On the news front, the HK biotech sector rallied for a second consecutive session, with AKESO up 4.33%, INNOVENT BIO up 3.92%, 3SBIO up 4.99%, BEIGENE up 3.6%, and SKB BIO up 7.44%, reflecting continued recovery in sector sentiment following the prior week's sell-off.</p><p>Additionally, the company previously announced that 193 million restricted shares from its IPO will become eligible for trading on July 1, representing 34.16% of total share capital. However, because the company has not met cash dividend distribution requirements under Shanghai Stock Exchange regulations, the unlocking shareholders are prohibited from reducing holdings through centralized bidding or block trading on A-shares. This regulatory restriction has substantially reduced actual selling pressure expectations, further alleviating market concerns over the potential overhang impact from the lock-up expiration.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09995","symbol_name":"荣昌生物","start_time":0,"source_url":"","article_id":"1183890100","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183890100","pubTimestamp":1782266158,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 24, RemeGen (09995.HK) rose 5.31% in regular trading, trading at HKD 70.05/share, with turnover of HKD 131 million.On the news front, the HK biotech sector rallied for a second consecutive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09995":"荣昌生物"},"translate_title":"动向提示|RemeGen在常规交易中上涨5.31%，随着禁售股限制缓解悬而未决的担忧，香港生物科技板块延续反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09995":1},"content_text":"On June 24, RemeGen (09995.HK) rose 5.31% in regular trading, trading at HKD 70.05/share, with turnover of HKD 131 million.On the news front, the HK biotech sector rallied for a second consecutive session, with AKESO up 4.33%, INNOVENT BIO up 3.92%, 3SBIO up 4.99%, BEIGENE up 3.6%, and SKB BIO up 7.44%, reflecting continued recovery in sector sentiment following the prior week's sell-off.Additionally, the company previously announced that 193 million restricted shares from its IPO will become eligible for trading on July 1, representing 34.16% of total share capital. However, because the company has not met cash dividend distribution requirements under Shanghai Stock Exchange regulations, the unlocking shareholders are prohibited from reducing holdings through centralized bidding or block trading on A-shares. This regulatory restriction has substantially reduced actual selling pressure expectations, further alleviating market concerns over the potential overhang impact from the lock-up expiration.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1183890100","isCrawlerRequest":true}